PT - JOURNAL ARTICLE AU - Wahid, Kareem A. AU - Lin, Diana AU - Sahin, Onur AU - Cislo, Michael AU - Nelms, Benjamin E. AU - He, Renjie AU - Naser, Mohammed A. AU - Duke, Simon AU - Sherer, Michael V. AU - Christodouleas, John P. AU - Mohamed, Abdallah S. R. AU - Murphy, James D. AU - Fuller, Clifton D. AU - Gillespie, Erin F. TI - Large-scale crowdsourced radiotherapy segmentations across a variety of cancer anatomic sites: Interobserver expert/non-expert and multi-observer composite tumor and normal tissue delineation annotations from a prospective educational challenge AID - 10.1101/2022.10.05.22280672 DP - 2023 Jan 01 TA - medRxiv PG - 2022.10.05.22280672 4099 - http://medrxiv.org/content/early/2023/02/17/2022.10.05.22280672.short 4100 - http://medrxiv.org/content/early/2023/02/17/2022.10.05.22280672.full AB - Clinician generated segmentation of tumor and healthy tissue regions of interest (ROIs) on medical images is crucial for radiotherapy. However, interobserver segmentation variability has long been considered a significant detriment to the implementation of high-quality and consistent radiotherapy dose delivery. This has prompted the increasing development of automated segmentation approaches. However, extant segmentation datasets typically only provide segmentations generated by a limited number of annotators with varying, and often unspecified, levels of expertise. In this data descriptor, numerous clinician annotators manually generated segmentations for ROIs on computed tomography images across a variety of cancer sites (breast, sarcoma, head and neck, gynecologic, gastrointestinal; one patient per cancer site) for the Contouring Collaborative for Consensus in Radiation Oncology challenge. In total, over 200 annotators (experts and non-experts) contributed using a standardized annotation platform (ProKnow). Subsequently, we converted data into NIfTI format with standardized nomenclature for ease of use. In addition, we generated consensus segmentations for experts and non-experts using the STAPLE method. These standardized, structured, and easily accessible data are a valuable resource for systematically studying variability in segmentation applications.Competing Interest StatementD.L. is in a research fellowship funded by grants for research and education related to eContour.org. B.E.N. is the founder of ProKnow and advisor to Elekta AB. J.P.C. is an employee of Elekta AB. C.D.F. has received direct industry grant support, speaking honoraria, and travel funding from Elekta AB. E.F.G. is a co-founder of the educational website eContour.org. The other authors have no conflicts of interest to disclose.Funding StatementThis work was supported by the National Institutes of Health (NIH)/National Cancer Institute (NCI) through a Cancer Center Support Grant (CCSG; P30CA016672-44; P30CA008748). D.L. is supported by the Radiological Society of North America (RSNA) Research Medical Student Grant (RMS2116). K.A.W. is supported by the Dr. John J. Kopchick Fellowship through The University of Texas MD Anderson UTHealth Graduate School of Biomedical Sciences, the American Legion Auxiliary Fellowship in Cancer Research, and an NIH/National Institute for Dental and Craniofacial Research (NIDCR) F31 fellowship (1 F31DE031502-01). E.F.G. and J.D.M. received funding from the Agency for Health Research and Quality (AHRQ R18HS026881). C.D.F. received funding from the NIH/NIDCR (1R01DE025248-01/R56DE025248); an NIH/NIDCR Academic-Industrial Partnership Award (R01DE028290); the National Science Foundation (NSF), Division of Mathematical Sciences, Joint NIH/NSF Initiative on Quantitative Approaches to Biomedical Big Data (QuBBD) Grant (NSF 1557679); the NIH Big Data to Knowledge (BD2K) Program of the NCI Early Stage Development of Technologies in Biomedical Computing, Informatics, and Big Data Science Award (1R01CA214825); the NCI Early Phase Clinical Trials in Imaging and Image-Guided Interventions Program (1R01CA218148); an NIH/NCI Pilot Research Program Award from the UT MD Anderson CCSG Radiation Oncology and Cancer Imaging Program (P30CA016672); an NIH/NCI Head and Neck Specialized Programs of Research Excellence (SPORE) Developmental Research Program Award (P50CA097007); and the National Institute of Biomedical Imaging and Bioengineering (NIBIB) Research Education Program (R25EB025787).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The research conducted herein was approved by the Human Research Protection Program (HRPP) at MSK (IRB#: X19-040 A(1); approval date: May 26, 2021)I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe raw data, records, and supplemental descriptions of the meta-data files are cited under Figshare doi: 10.6084/m9.figshare.21074182 (private until manuscript acceptance).